- Home
- HWH vs KZIA Comparison
HWH vs KZIA Comparison
Compare HWH & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWH
- KZIA
- Stock Information
- Founded
- HWH 2021
- KZIA 1994
- Country
- HWH United States
- KZIA Australia
- Employees
- HWH N/A
- KZIA N/A
- Industry
- HWH Other Pharmaceuticals
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- HWH Health Care
- KZIA Health Care
- Exchange
- HWH Nasdaq
- KZIA Nasdaq
- Market Cap
- HWH 21.2M
- KZIA 18.7M
- IPO Year
- HWH N/A
- KZIA 1999
- Fundamental
- Price
- HWH $0.50
- KZIA $3.18
- Analyst Decision
- HWH
- KZIA Strong Buy
- Analyst Count
- HWH 0
- KZIA 1
- Target Price
- HWH N/A
- KZIA $20.00
- AVG Volume (30 Days)
- HWH 2.3M
- KZIA 77.0K
- Earning Date
- HWH 12-27-2024
- KZIA 12-27-2024
- Dividend Yield
- HWH N/A
- KZIA N/A
- EPS Growth
- HWH N/A
- KZIA N/A
- EPS
- HWH N/A
- KZIA N/A
- Revenue
- HWH $1,174,367.00
- KZIA $1,655,324.00
- Revenue This Year
- HWH N/A
- KZIA $806.89
- Revenue Next Year
- HWH N/A
- KZIA N/A
- P/E Ratio
- HWH N/A
- KZIA N/A
- Revenue Growth
- HWH 44.55
- KZIA 248000.00
- 52 Week Low
- HWH $0.41
- KZIA $1.90
- 52 Week High
- HWH $10.65
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- HWH 38.56
- KZIA 29.92
- Support Level
- HWH $0.55
- KZIA $3.00
- Resistance Level
- HWH $0.72
- KZIA $4.20
- Average True Range (ATR)
- HWH 0.16
- KZIA 0.56
- MACD
- HWH -0.04
- KZIA -0.15
- Stochastic Oscillator
- HWH 0.01
- KZIA 5.82
About HWH HWH International Inc.
HWH International Inc is a purpose-driven lifestyle company enabling home-based people in the new GIG economy to create lasting wealth. Developing new pathways in the aid of helping people in their pursuit of Health, Wealth and Happiness.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.